Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts.
Times cited: 8
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation.
Times cited: 10
PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas.
Times cited: 45